Suchergebnisse - "Demirkan, Kutay"

PubPharm (9)

1

Benefit versus toxicity risk of digoxin in patients with COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2022

von Kelleci Cakir, B. | Bayraktar-Ekincioglu, A. | Demirkan, K.

2

Challenge in treating COVID-19 associate pulmonary aspergillosis : Supratherapeutic voriconazole levels

enthalten in: British journal of clinical pharmacology | 2022

von Bakir Ekinci, P. | Kara, E. | Er, A. | +3

3

The potential interaction between COVID-19 vaccines and clozapine : A novel approach for clinical trials

enthalten in: International journal of clinical practice | 2021

von Bayraktar, �. | Yalçın, N. | Demirkan, K.

4

COVID-19 and remdesivir in pediatric patients : the invisible part of the iceberg

enthalten in: Pediatric research | 2021

von Yalçın, N. | Demirkan, K.

CommentOn: Pediatrics. 2020 Jul;146(1):. - PMID 32366611

5

Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?

enthalten in: European journal of hospital pharmacy : science and practice | 2021

von Yalçın, N. | Ak, S. | Demirkan, K.

6

The another side of COVID-19 in Alzheimer's disease patients : Drug-drug interactions

enthalten in: International journal of clinical practice | 2020

von Balli, N. | Kara, E. | Demirkan, K.

CommentOn: Lancet. 2020 Apr 11;395(10231):1190-1191. - PMID 32240625

7

Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19

enthalten in: International journal of antimicrobial agents | 2020

von Kara, E. | Demirkan, K. | Unal, S.

8

COVID-19 & antiepileptic drugs : Should we pay attention?

enthalten in: Seizure | 2020

von Fırat, O. | Yalçın, N. | Demirkan, K.

CommentIn: Seizure. 2021 Mar;86:80-81. - PMID 33578259

9

May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?

enthalten in: International journal of antimicrobial agents | 2020

von Kara, E. | Inkaya, A. | Demirkan, K.

1
[1]